Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics reported after the close of the market Monday a 26 percent drop in its third quarter revenues due to declines across its biopharma, clinical, and discovery services units.

For the three-month period ended Sept. 30, Rutherford, New Jersey-based CGI posted revenues of $5.9 million versus $8.0 million in the same period a year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.